Abdulla A. Damluji/X
Nov 18, 2025, 08:52
Aspirin or P2Y12 Monotherapy?
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared a post on X:
“Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?
Very nice review.”
Stay informed with Hemostasis Today.
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story
-
Oct 7, 2026, 14:49Aimee Burtenshaw: The Impact of the Infected Blood Inquiry on hospital Transfusion Laboratories
-
Oct 7, 2026, 14:41Vikash Jaiswal: Does Timing Matter for Calcium in Pre-Eclampsia Prevention?
-
Oct 7, 2026, 14:34Pre-Registration Ends for Our Webinar on Pregnancy and Thrombotic Risk – World Thrombosis Day
-
Oct 7, 2026, 14:19Maha Othman: Celebrating the Opening of The Current at St. Lawrence College
-
Oct 7, 2026, 14:12Zahra Ghasemi: The Role of Recovered and Source Plasma in Plasma Fractionation
-
Oct 7, 2026, 14:09Ney Carter Borges: How ApoB and Lp(a) Shape Coronary Plaque Risk